Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
CVM Publications - Detail
FDA Home
CVM Publications
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
TITLE:
Antimicrobial resistance: responsible and prudent use of antimicrobial agents in veterinary medicine
AUTHORS:
Anthony F;Acar J;Franklin A;Gupta R;Nicholls T;Tamura Y;Thompson S;Threlfall EJ;Vose D;van VM;White DG;
YEAR:
2001
JOURNAL ABBREV:
Rev Sci Tech
MONTH:
Dec
TYPE:
JOUR
REFMAN INDEX:
254
JOURNAL FULL:
Revue scientifique et technique (International Office of Epizootics)
VOLUME:
20
ISSUE:
3
START PAGE:
829
END PAGE:
839
KEYWORDS:
Animal Husbandry;Animals;Anti-Bacterial Agents;Bacteria;Bacterial Infections;Drug and Narcotic Control;Drug Industry;Drug Resistance,Bacterial;drug therapy;Food;Humans;Pharmacists;prevention & control;Product Surveillance,Postmarketing;Quality Control;standards;therapeutic use;veterinary;Veterinary Medicine;
ABSTRACT:
A guideline on the responsible and prudent use of antimicrobials in animal husbandry has been developed by the Ad hoc Group of experts on antimicrobial resistance, created by the Office International des Epizooties. The objectives of responsible use are to maintain antibiotic efficacy, to avoid the dissemination of resistant bacteria or resistance determinants and to avoid the exposure of humans to resistance through food. The guideline attributes a central role to the competent authorities responsible for granting marketing authorizations for antimicrobial substances. Requirements before and after granting of marketing authorizations are defined. Important aspects include the control of the pharmaceutical product quality and the therapeutic efficacy, the assessment of the selection pressure, the protection of the environment, specific and non-specific antimicrobial resistance surveillance. The guideline is also addressed to the veterinary pharmaceutical industry, veterinary practitioners, dispensing pharmacists and farmers. The respective roles and responsibilities of these groups are defined
AFFILIATIONS:
Universite Pierre et Marie Curie, Service de Microbiologie Medicale, Fondation Hopital Saint-Joseph, 185 rue Raymond Losserand, 75674 Paris, France
-
-